Once revolutionary, now dominant: OCT still shows rich potential for new applications

Each B-scan consists of PA-scans acquired sequentially along the x-direction. An OCT volume consists of QB-scan images acquired along the y-direction. Pixels along the y-direction from N adjacent B-scans were used to determine the frequency components. (Fig. 1 from 10.1117/1.JBO.22.12.121710) Credit: Jordi L. Tremoleda; Karl Alvarez; Abdirahman Aden; Robert Donnan; Adina T. Michael-Titus; Peter H. Tomlins

Optical coherence tomography (OCT) has revolutionized ophthalmology in the 25 years since the technology's inception, by providing the capability to noninvasively measure and create 3D images at the microscopic scale of tissues inside the body. Now increasingly used in cardiology, dermatology, and other medical specialties, new opportunities continue to emerge across a wide range of fields beyond medicine and biology.

Now the dominant diagnostic tool for conditions such as macular degeneration and glaucoma, OCT technology continues to offer potential in areas from fundamental research to clinical applications.

A special section on OCT published by SPIE, the international society for optics and photonics, in the December issue of the Journal of Biomedical Optics (JBO) provides an expert perspective on applications in medicine and biology, particularly those outside ophthalmology. Guest editors are David Sampson (University of Surrey), Peter Andersen (Technical University of Denmark), Ton van Leeuwen (Academisch Medisch Centrum), and Ruikang (Ricky) Wang (University of Washington).

The special section illustrates how, as the technology has matured and some applications have reduced in cost, fresh opportunities pave the way for a new generation of OCT technology translators. OCT remains true to the spirit of the broader field of biophotonics itself, the guest editors noted, with the focus on practical engineering to tackle practical challenges. OCT as a research topic is vibrant and robust, with many new opportunities waiting in the wings for clinical and commercial applications.

Among topics covered in the section's 20 papers are:

  • The emerging application areas of gastroenterology, dermatology, and oncology, as well as more speculative earlier stage clinical applications in gynecology.
  • Visible-light OCT and ocular biomechanics probed with OCT, in ophthalmology. In “Spectroscopic Doppler analysis for visible-light optical coherence tomography,” Xiao Shu (Northwestern University) et al. discuss a method for quantifying oxygen saturation and retinal blood flow velocity in vivo.
  • The capability to hold the imaging instrument in hand — an enabling technology for a raft of applications. Guillermo Monroy (University of Illinois at Urbana-Champaign) discusses handheld OCT systems that pave the way for widespread adoption of OCT into point-of-care or point-of-procedure applications in both clinical and commercial settings.
  • Polarization-sensitive OCT, with applications in treating osteoarthritis, burn scars, and oral tissues. “Quantitative light-induced fluorescence technology for quantitative evaluation of tooth wear,” by Sang-Kyeom Kim (Yonsei University College of Dentistry) et al. describe a noninvasive tool to monitor the progression of tooth wear and estimate enamel thickness.
  • Angiography applications, including imaging of the retina and brain. Zhongdi Chu (University of Washington) et al. describe one application in “Complex signal-based optical coherence tomography angiography enables in vivo visualization of choriocapillaris in human choroid.”

The special section also includes a historical account of the life and work of a pioneer of OCT, Adolf Fercher, who died in March 2017, written by his close colleague Christoph Hitzenberger (Medical University of Vienna).

Brian Pogue, Professor of Engineering at Thayer School of Engineering at Dartmouth, is the editor-in-chief of the Journal of Biomedical Optics. The journal is published in print and digitally by SPIE in the SPIE Digital Library, which contains more than 460,000 articles from SPIE journals, proceedings, and books, with approximately 18,000 new research papers added each year. The journal will become fully open access on 1 January 2019.

###

About SPIE

SPIE is the international society for optics and photonics, an educational not-for-profit organization founded in 1955 to advance light-based science, engineering, and technology. The Society serves nearly 264,000 constituents from approximately 166 countries, offering conferences and their published proceedings, continuing education, books, journals, and the SPIE Digital Library. In 2017, SPIE provided more than $4 million in support of education and outreach programs. http://www.spie.org

Media Contact

Kevin Probasco
kevinp@spie.org
360-685-5525

 @SPIEtweets

http://spie.org/ 

Media Contact

Kevin Probasco EurekAlert!

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Superradiant atoms could push the boundaries of how precisely time can be measured

Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…

Ion thermoelectric conversion devices for near room temperature

The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…

Zap Energy achieves 37-million-degree temperatures in a compact device

New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…

Partners & Sponsors